Daejoon Anh, MD
Clinical Cardiac Electrophysiology · Henderson, NVNPI 1033218839
Payments from drug & device makers
What this record shows
This record is dominated by food and beverage: $28,031 of the $32,539 with a category attached, or 86.1%. 21 manufacturers reported payments, led by Medtronic at 46.5% of the total.
Across 356 payments — averaging $91.40 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Medtronic$15K
- Abbott$12K
- Inspire Medical Systems, Inc.$1K
- Boston Scientific$1K
- Impulse Dynamics (USA) Inc.$910
- Cvrx, Inc.$323
- plus $2K from 15 others
Across 16 payments — averaging $721.13 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Abbott$12K
What the payments were for
- Consulting fees$2,9259%
- Travel & lodging$1,5835%
- Food & beverage$28,03186%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Medtronic(2 entities) | 175 | $15,116 |
| Abbott | 109 | $12,262 |
| Inspire Medical Systems, Inc. | 5 | $1,107 |
| Boston Scientific | 21 | $1,035 |
| Impulse Dynamics (USA) Inc. | 9 | $910 |
| Cvrx, Inc. | 2 | $323 |
| Biotronik Inc. | 2 | $311 |
| Akcea Therapeutics, Inc. | 2 | $237 |
| Novartis | 9 | $179 |
| Amgen | 4 | $179 |
| Philips North America LLC | 7 | $166 |
| Atricure, Inc. | 1 | $156 |
| Janssen Scientific Affairs, LLC | 1 | $150 |
| Biosense Webster, Inc. | 1 | $140 |
| Abiomed | 1 | $137 |
| Teleflex LLC | 1 | $33 |
| Johnson & Johnson | 2 | $26 |
| Novo Nordisk | 1 | $22 |
| Lantheus Medical Imaging, Inc. | 1 | $21 |
| W. L. Gore & Associates, Inc. | 1 | $19 |
| Baylis Medical Company Inc | 1 | $12 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Micra$3,205
- Accent Pacemaker$3,101
- ENSITE$1,803
- SelectSecure$1,631
- OPTIMIZER$1,301
- Cobalt$1,057
- EnSite Precision Cardiac Mapping System$941
- ENSITE PRECISION$918
- AZURE XT DR MRI SURESCAN$911
- COBALT DR MRI SURESCAN$731
- Amplia MRI$639
- Inspire Upper Airway Stimulation System$634
- AMPLATZER AMULET$505
- Inspire$473
- Claria MRI$446
- Farapulse$413
- EP-WorkMate Claris System$343
- Azure$337
- QUADRA ASSURA$327
- AFFERA MAPPING SYSTEM$323
How this compares
$32,539 in reported general payments places this provider in the 80th percentile of 20 clinical cardiac electrophysiology providers in Nevada.
See all clinical cardiac electrophysiology providers in Nevada →
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| EliquisApixaban | 679 | $818,146 |
| EntrestoSacubitril/Valsartan | 117 | $160,211 |
| XareltoRivaroxaban | 126 | $135,500 |
| JardianceEmpagliflozin | 40 | $53,190 |
| FarxigaDapagliflozin Propanediol | 38 | $20,502 |
| Dofetilide | 74 | $11,683 |
| InvokanaCanagliflozin | 12 | $6,755 |
| Rosuvastatin Calcium | 456 | $5,433 |
| Flecainide Acetate | 131 | $4,185 |
| Dabigatran EtexilateDabigatran Etexilate Mesylate | 15 | $3,980 |
| Metoprolol Succinate | 319 | $3,526 |
| Amiodarone Hcl | 241 | $2,892 |
| Olmesartan Medoxomil | 164 | $2,557 |
| Carvedilol | 333 | $1,760 |
| Digoxin | 120 | $1,748 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| NovartisEntresto | $179 | $160,211117 claims |
| Johnson & JohnsonXarelto, Invokana | $26 | $142,255138 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 80th percentile of 20 clinical cardiac electrophysiology providers in Nevada.
Other clinical cardiac electrophysiology in Henderson
- Claudio BonomettiLas Vegas$89K
- Erik SirulnickLas Vegas$44K
- Niuton KoideLas Vegas$34K
- Jeffrey TurnerCarson City$32K
- David NavratilLas Vegas$29K
- Shining SunReno$22K
- Ruifang YangReno$20K
- Joshua LeichmanReno$17K
- Dhiraj NarulaLas Vegas$14K
- Juan Rodriguez ReyesSparks$11K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.